Download Sample
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Clinical Laboratory Services Market: By Test Type, By Service Provider, By Application and Region Forecast 2020-2031
Clinical Laboratory Services Market: By Test Type, By Service Provider, By Application and Region Forecast 2020-2031
Clinical Laboratory Services Market size was valued at US$ 241.4 billion in 2024 and is expected to reach US$ 307.2 billion by 2031, growing at a significant CAGR of 3.5% from 2025-2031. Clinical laboratory services are a very important part of the healthcare industry. These laboratories provide various services such as blood tests, diagnostic tests, and genetic tests for identifying the disease's causes and play a major role in the drug discovery process. Furthermore, clinical laboratory services provide information and offer services to improve the efficiency of healthcare systems such as diagnostic and test reports. The revolution of genetic testing and biopharmaceuticals has led to the emergence of new diagnostic procedures that involve laboratory testing.
According to a 2018 World Health Organization (WHO) report, tuberculosis (TB) was one of the top ten causes of mortality worldwide. In 2018, 1.5 million people died from tuberculosis (including 251,000 people with HIV). For instance, in October 2017, Abbot Laboratories acquired Alere Inc., a leader in point-of-care diagnostics and clinical laboratory services providers to strengthen its product portfolio. In May 2017, LabCorp, has acquired Pathology Associates Medical Laboratories (PAML), a premier medical reverence laboratory and healthcare solution company in Washington, to expand its geographic presence. In September 2017, Quest Diagnostics, a leading provider of diagnostic information services entered into an agreement to acquire Shiel Medical Laboratory business from Fresenius Medical Care, to expand its services. In June 2015, Laboratory Corporation of America Holdings and Sysmex Corporation entered into a strategic collaboration to develop blood-based molecular diagnostics tests to advance precision medicine.
Study Period
2025-2031Base Year
2024CAGR
5.3%Largest Market
North-AmericaFastest Growing Market
Asia-Pacific
The market is mainly driven by the prevalence of diseases such as cancer, infectious diseases and diabetes that require the clinical diagnosis of samples. In addition, growth in adoption of clinical service outsourcing and aging population who are more susceptible to the diseases expected to boost the market over the forecast period. Furthermore, technological advancements that led to speeding up the testing and diagnosis and introduction of advanced products such as microarrays and lab on chips are projected to bolster the market growth. The increase in demand for companion diagnostics also acting as driving factor for market growth. However, lack of skilled professionals and stringent regulatory procedures may impend the market over the forecast period.
North America is expected to grow at significant rates owing to factors such as growing research and development in biotechnological field that requires clinical testing and presence and well-established healthcare infrastructure and growing prevalence of diseases such as cardiovascular diseases, cancer, and infectious diseases. Asia Pacific region is expected to have significant growth rate owing to factors such as developing healthcare infrastructure and increase in funding for R&D in the field of healthcare for developing new drugs and diagnosis of diseases. Europe is expected to grow at notable rates owing to the presence of many local and multinational players who are actively involving in acquisitions and mergers to increase their market share. Furthermore, growing aging population in this region who are susceptible to the diseases may drive the market growth.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2025-2031 |
|
Market Size in 2024 |
US$ 241.4 billion |
|
Market Size in 2031 |
US$ 307.2 billion |
|
Market CAGR |
5.3% |
|
By Test Type |
|
|
By Service Provider |
|
|
By Application |
|
|
By Region |
|
Download Free Sample Report
Clinical laboratory services market size was valued at US$ 241.4 billion in 2024 and is expected to reach US$ 307.2 billion by 2031, growing at a significant CAGR of 3.5% from 2025-2031.
Bio-Reference Laboratories Inc. (OPKO Health) (U.S.), Alere, Inc. (Abbott Laboratories) (U.S., DaVita Healthcare Partners, Inc. U.S.), Laboratory Corporation of America Holdings (U.S.), Genomic Health, Inc. (U.S.)
North America is the fastest-growing region in the market
| 1.Executive Summary |
| 2.Global Clinical Laboratory Services Market Introduction |
| 2.1.Global Clinical Laboratory Services Market - Taxonomy |
| 2.2.Global Clinical Laboratory Services Market - Definitions |
| 2.2.1. By Test Type |
| 2.2.2. By Service Provider |
| 2.2.3. By Application |
| 2.2.4. By Region |
| 3.Global Clinical Laboratory Services Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Clinical Laboratory Services Market Analysis, 2020 - 2024 and Forecast 2025 - 2031 |
| 4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Clinical Laboratory Services Market By Test Type, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 5.1. Clinical Chemistry |
| 5.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Medical Cytology & Microbiology |
| 5.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Human & Tumor Genetics |
| 5.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 6.Global Clinical Laboratory Services Market By Service Provider, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 6.1. Hospitals Based |
| 6.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Standalone Laboratories |
| 6.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Clinical Laboratories |
| 6.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 7.Global Clinical Laboratory Services Market By Application, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 7.1. Gene Therapy |
| 7.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Toxicological Study |
| 7.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Drug Discovery and Development |
| 7.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Pre-clinical & Clinical Trial Services |
| 7.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Others |
| 7.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 8.Global Clinical Laboratory Services Market By Region, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia Pacific (APAC) |
| 8.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Middle East and Africa (MEA) |
| 8.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Latin America |
| 8.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9.North America Clinical Laboratory Services Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 9.1. Test Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Clinical Chemistry |
| 9.1.2.Medical Cytology & Microbiology |
| 9.1.3.Human & Tumor Genetics |
| 9.2. Service Provider Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Hospitals Based |
| 9.2.2.Standalone Laboratories |
| 9.2.3.Clinical Laboratories |
| 9.3. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Gene Therapy |
| 9.3.2.Toxicological Study |
| 9.3.3.Drug Discovery and Development |
| 9.3.4.Pre-clinical & Clinical Trial Services |
| 9.3.5.Others |
| 9.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.4.1.United States of America (USA) |
| 9.4.2.Canada |
| 10.Europe Clinical Laboratory Services Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 10.1. Test Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Clinical Chemistry |
| 10.1.2.Medical Cytology & Microbiology |
| 10.1.3.Human & Tumor Genetics |
| 10.2. Service Provider Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Hospitals Based |
| 10.2.2.Standalone Laboratories |
| 10.2.3.Clinical Laboratories |
| 10.3. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Gene Therapy |
| 10.3.2.Toxicological Study |
| 10.3.3.Drug Discovery and Development |
| 10.3.4.Pre-clinical & Clinical Trial Services |
| 10.3.5.Others |
| 10.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Germany |
| 10.4.2.France |
| 10.4.3.Italy |
| 10.4.4.United Kingdom (UK) |
| 10.4.5.Spain |
| 11.Asia Pacific (APAC) Clinical Laboratory Services Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 11.1. Test Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Clinical Chemistry |
| 11.1.2.Medical Cytology & Microbiology |
| 11.1.3.Human & Tumor Genetics |
| 11.2. Service Provider Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Hospitals Based |
| 11.2.2.Standalone Laboratories |
| 11.2.3.Clinical Laboratories |
| 11.3. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Gene Therapy |
| 11.3.2.Toxicological Study |
| 11.3.3.Drug Discovery and Development |
| 11.3.4.Pre-clinical & Clinical Trial Services |
| 11.3.5.Others |
| 11.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.China |
| 11.4.2.India |
| 11.4.3.Australia and New Zealand (ANZ) |
| 11.4.4.Japan |
| 11.4.5.Rest of APAC |
| 12.Middle East and Africa (MEA) Clinical Laboratory Services Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 12.1. Test Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Clinical Chemistry |
| 12.1.2.Medical Cytology & Microbiology |
| 12.1.3.Human & Tumor Genetics |
| 12.2. Service Provider Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Hospitals Based |
| 12.2.2.Standalone Laboratories |
| 12.2.3.Clinical Laboratories |
| 12.3. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Gene Therapy |
| 12.3.2.Toxicological Study |
| 12.3.3.Drug Discovery and Development |
| 12.3.4.Pre-clinical & Clinical Trial Services |
| 12.3.5.Others |
| 12.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.GCC Countries |
| 12.4.2.South Africa |
| 12.4.3.Rest of MEA |
| 13.Latin America Clinical Laboratory Services Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 13.1. Test Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Clinical Chemistry |
| 13.1.2.Medical Cytology & Microbiology |
| 13.1.3.Human & Tumor Genetics |
| 13.2. Service Provider Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Hospitals Based |
| 13.2.2.Standalone Laboratories |
| 13.2.3.Clinical Laboratories |
| 13.3. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Gene Therapy |
| 13.3.2.Toxicological Study |
| 13.3.3.Drug Discovery and Development |
| 13.3.4.Pre-clinical & Clinical Trial Services |
| 13.3.5.Others |
| 13.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Brazil |
| 13.4.2.Mexico |
| 13.4.3.Rest of LA |
| 14. Competition Landscape |
| 14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 14.2.1.Genomic Health, Inc. (U.S.) |
| 14.2.2.Myriad Genetics, Inc. (U.S.) |
| 14.2.3.Quest Diagnostics, Inc. (U.S.) |
| 14.2.4.NeoGenomics, Inc. (U.S.) |
| 14.2.5.Alere, Inc. (Abbott Laboratories) (U.S.) |
| 14.2.6.DaVita Healthcare Partners, Inc. U.S.) |
| 15. Research Methodology |
| 16. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.